ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 154 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 2.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $68,000 | -16.0% | 15,842 | +13.5% | 0.00% | 0.0% |
| Q2 2019 | $81,000 | -65.5% | 13,952 | -67.3% | 0.00% | -66.7% |
| Q2 2016 | $235,000 | -67.1% | 42,723 | -55.7% | 0.00% | -62.5% |
| Q1 2016 | $715,000 | -21.9% | 96,406 | -12.5% | 0.01% | -20.0% |
| Q4 2015 | $915,000 | -22.1% | 110,163 | +1.0% | 0.01% | +11.1% |
| Q1 2015 | $1,175,000 | – | 109,080 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |